Ottawa Memory Clinic

Ottawa, Ontario K1Z 1G3

1 studies enrolling now · 11 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Alzheimers Disease, Early Alzheimer's Disease, Early Alzheimer´s Disease, Moderate Alzheimer Disease

Studies at this site

• Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease — Recruiting now
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease — Recruiting now
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
• A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
• A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease — Completed
• A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease — Completed
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early
• Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients — Completed
• Neuro RX Gamma - Pivotal Phase — Paused